A Comparative Study Between Analgesic Effect of Opioid Free and Opioid Based Anesthesia in Radical Nephrectomy Surgery

A Comparative Study Between Analgesic Effect of Opioid Free and Opioid Based General Anesthesia Technique in Patients Undergoing Open Radical Nephrectomy Surgery.A Prospective Randomized Controlled Trial

Patients undergoing nephrectomy have a high incidence of postoperative pain. In the perioperative period, these patients are often treated with patient-controlled opioids, epidural analgesia, or both. While effective, both of these treatment modalities carry risk, ie, opioids have a side effect profile including pruritus, nausea,vomiting, increase the risk of oversedation and apnea in patients at risk (eg, those with sleep apnea), difficulty in voiding, and ileus. These complications may lead to a prolonged hospital stay. High dose opioids can also cause acute opioid tolerance and hyperalgesia. Epidurals have been associated with hypotension, post dural puncture headaches, changes in management of anticoagulation Opioid free anesthesia (OFA) is a technique in which no intraoperative opioid administered through any route, including systemic, neuraxial, or tissue infiltration.Opioid free anesthesia has many advantages especially avoiding opioid overdose and opioid-induced hyperalgesia. The most important advantage of OFA seems to be the potential improvement of recovery profile in obese patients. OFA depends on combinations of non-opioid agents and adjuncts, including propofol, lidocaine, magnesium, dexmedetomidine, and ketamine to produce anesthesia, and analgesia.

Aim of the work our study aim to compare the analgesic effect of OFA and opioid based general anesthesia using pre emptive wound infiltration in patients undergoing open radical nephrectomy surgery.

Objectives:

1. To evaluate analgesic effect of each group intra operative {heart rate, and systolic and diastolic blood pressure }
2. To evaluate analgesic effect of each group post operative [total opioid consumption in 24h postoperative , Postoperative VAS , hemodynamic).
3. To estimate the incidence of early postoperative complication in both groups

Study Overview

• Status: Recruiting
• Conditions: Opioid Free Anesthesia
• Intervention / Treatment: Procedure: pre emptive local anaesthetic wound infiltration

Detailed Description

This a randomized control trial is designed to include (74) patients ASA physical status II patients ranging from(18) to(70)years old scheduled for open radical nephrectomy

Patients meeting the inclusion criteria will be randomly assigned to receive either :

Group I :Opioid Based Anesthesia (n=37) GroupII: Opioid Free Anesthesia:(n=37) Anesthesia management

Preoperative procedures:

Full history and investigation will be taken in the form of complete blood count , blood sugar,liver function tests. Kidney function tests ,electrolytes and coagulation profile. Pre induction of general anesthesia with gabapentin 300 mg tab or placebo 1 h before surgery while gabapentin in (Opioid free Anesthesia) and placebo in (Opioid Based Anesthesia) . After securing IV access by 20G cannula, all patients will receive 0.05mg/kg midazolam for anxiety. Ranitidine 50mg, metoclopramide 10mg and antibiotic 50mg/kg as a premedication.Intraoperative monitoring includes ASA standard monitoring Electrocardiography (ECG), noninvasive blood pressure, pulse oximetry for O2 saturation, end-tidal carbon dioxide (CO2) values by capnography.

Intraoperative procedures:

Induction of general anesthesia in both groups will be done by 2mg \kg propofol, and 0.5mg\kg atracurium. to facilitate endotracheal intubation, with fentanyl1ug/kg/ iv then infusion of 1 ug/kg/h in group I (Opioid Based Anesthesia) and with ketamine 0.5 mg/kg iv, Lidocaine 1 mg/kg iv then continuous infusion with 2 mg/kg/hr, dexamethasone 0.1 mg/kg.iv, magnesium sulfate 20 mg/kg.iv in group II (Opioid Free Anesthesia) after induction.

Anesthesia maintenance will be achieved in both group with endotracheal tube (ETT) with suitable size, 1.2 minimium alveolar concentration of isoflurane, volume controlled mode ventilation, respiratory rate will be adjusted according to Et CO2 to range between 35-40 mmHg, a tidal volume of 6-8 ml/kg and mixture of gases in proportion 50% oxygen and 50% air, with positive end expiratory pressure (PEEP) 5 cm H2O and0.1 mg\kg atracurium every 30 min.

Intervention Before skin incision by 15 min the surgeon will infiltrate the wound by syringe containing 20 ml mixture of (10 ml xylocaine 2%and 10 ml bupivacaine 0. 5%) in both groups. By the end of surgery, anaesthesia will be discontinued ,patient will be reversed by neostigmine 0.05mg\kg and atropine0.02mg\kg, extubation will be done and patient will be transferred to post anaesthesia care unit (PACU).

Postoperative

1. The pain assessment after full recovery will be performed using a 10 cm visual analog scale (VAS) (0- no pain and 10 cm maximum pain) .Postoperative pain assessments using VAS at 0 point (the full recovery state which is defined as a state of consciousness of individual when he is awake or easily arousable and aware of his surroundings and identity, 2 hr, 6 hr, 12 hr, and at 24 hr. IV paracetamol 1 g every 6 hours will be administered for both groups.

   The time to first request of postoperative analgesic is defined as( the time interval from tracheal extubation to first dose of morphine adminstration) will be recorded .Rescue postoperative analgesic will be administrated if VAS ≥ 4 at rest or on patient's demand with IV morphine sulphate 0.03 mg/kg with maximum dose 20 mg per day in both groups .the total amount of morphine in the first postoperative 24 hours will be calculated in both groups.

2. Post operative hemodynamic will be assessed(heart rate ,systolic and diastolic blood pressure at the same time point)

3. Incidence of complication will be assessed:

   • Nausea and vomiting
   • Respiratory complications(bronchospasm , laryngospasm , respiratory depression)

Measurement tools

1. Patients demographic data will be collected; age, gender, and duration of anesthesia
2. Intraoperative hemdynamic (Heart rate ,systolic and diastolic blood pressure).
3. Postoperative pain assessments using VAS at at 0 point (the full recovery state), 2 hr, 6 hr, 12 hr, and at 24 hr
4. Time to first request of rescue postoperative analgesic
5. Total opioid consumption in 24 h postoperative
6. Postoperative hemdynamic (Heart rate ,systolic and diastolic blood pressure at the same time point)

• Study Type: Interventional
• Enrollment (Anticipated): 74
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt, 202
    • Recruiting
    • Kasr Alainy, Cairo University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 70 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Gender both males and females
2. ASA Class II
3. Age 18-70 years
4. Patients undergoing open radical nephrectomy

Exclusion Criteria:

1. Allergy to local anesthetic
2. Infection of the skin at the site of local infiltration
3. Cvs problem(ischemic heart disease,arrhythmias{heart block, supraventricular tachyarrhythmia (SVT),atrial fibrillation (AF),multiple extra systole)
4. Liver and renal impairment(elevated liver enzymes (ALT, AST two to three fold), chronic renal failure (CRF) )

Study Plan

How is the study designed?

Design Details

• Primary Purpose: PREVENTION
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: DOUBLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
PLACEBO_COMPARATOR: Opioid Based Anesthesia; Pre induction of general anesthesia with placebo 1 h before surgery. induction of general anesthesia with fentanyl1ug/kg/ iv then infusion of 1 ug/kg/h	Procedure: pre emptive local anaesthetic wound infiltration; Before skin incision by 15 min the surgeon will infiltrate the wound by syringe containing 20 ml mixture of (10 ml xylocaine 2%and 10 ml bupivacaine 0. 5%) in both groups; Other Names: xylocaine and bupivacaine local anaesthetic mixture
ACTIVE_COMPARATOR: opioid free anesthesia; Pre induction of general anesthesia with gabapentin 300 mg tab 1 h before surgery. induction of general anesthesia with ketamine 0.5 mg/kg iv, Lidocaine 1 mg/kg iv then continuous infusion with 2 mg/kg/hr, dexamethasone 0.1 mg/kg.iv, magnesium sulfate 20 mg/kg.iv	Procedure: pre emptive local anaesthetic wound infiltration; Before skin incision by 15 min the surgeon will infiltrate the wound by syringe containing 20 ml mixture of (10 ml xylocaine 2%and 10 ml bupivacaine 0. 5%) in both groups; Other Names: xylocaine and bupivacaine local anaesthetic mixture

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Time to first request of opioid analgesia	the time interval between tracheal extubation and the first request to postoperative analgesia	it will be measured from tracheal extubation to first request of postoperative analgesia in the first 24 hours postoperative and it will be expressed in minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Total opioid consumption	total amount of morphine in the first postoperative 24 hours	the total amount of morphine in the first postoperative 24 hours will be calculated
Postoperative VAS score	The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."	Postoperative pain assessments using VAS at 0 point (the full recovery state ), 2 hours, 6 hours, 12 hours,and at 24 hours postoperative.

Collaborators and Investigators

• Sponsor: Kasr El Aini Hospital
• Collaborators: Cairo University
• Investigators: Study Director: Heba ismail, professor, Anesthesia department , Cairo university

Study record dates

Study Major Dates

• Study Start (ACTUAL): April 10, 2022
• Primary Completion (ANTICIPATED): September 1, 2022
• Study Completion (ANTICIPATED): September 1, 2022

Study Registration Dates

• First Submitted: March 12, 2022
• First Submitted That Met QC Criteria: April 2, 2022
• First Posted (ACTUAL): April 5, 2022

Study Record Updates

• Last Update Posted (ACTUAL): May 10, 2022
• Last Update Submitted That Met QC Criteria: May 7, 2022
• Last Verified: May 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Physiological Effects of Drugs; Central Nervous System Depressants; Peripheral Nervous System Agents; Sensory System Agents; Anesthetics; Anesthetics, Local; Bupivacaine
• Other Study ID Numbers: N-2-2022

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No